Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

National Research (NRC) EBITDA: 2009-2024

Historic EBITDA for National Research (NRC) over the last 16 years, with FY2024 value amounting to $35.2 million.

  • National Research's EBITDA fell 303.26% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 2627.43%. This contributed to the annual value of $35.2 million for FY2024, which is 1211.39% down from last year.
  • Latest data reveals that National Research reported EBITDA of $35.2 million as of FY2024, which was down 1211.39% from $40.0 million recorded in FY2023.
  • Over the past 5 years, National Research's EBITDA peaked at $50.3 million during FY2021, and registered a low of $35.2 million during FY2024.
  • Its 5-year average for EBITDA is $42.9 million, with a median of $42.7 million in 2020.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 1779.18% in 2021, then crashed by 1396.13% in 2023.
  • Over the past 5 years, National Research's EBITDA (Annual) stood at $42.7 million in 2020, then rose by 17.79% to $50.3 million in 2021, then decreased by 7.41% to $46.5 million in 2022, then decreased by 13.96% to $40.0 million in 2023, then dropped by 12.11% to $35.2 million in 2024.
  • Its last three reported values are $35.2 million in FY2024, $40.0 million for FY2023, and $46.5 million during FY2022.